Literature DB >> 28330683

Insight into pathogenesis of Sjögren's syndrome: Dissection on autoimmune infiltrates and epithelial cells.

Andreas V Goules1, Efstathia K Kapsogeorgou2, Athanasios G Tzioufas3.   

Abstract

Sjögren's syndrome (SS) is a chronic autoimmune disease with broad clinical spectrum, extending from benign exocrinopathy to severe systemic disease and lymphoma development. The glandular and extraglandular dysfunction of SS is associated with lymphocytic infiltrates that invade the epithelial structures of affected organs. The in-depth study of autoimmune lesions in the minor salivary glands (MSG), which are the major target-organ of SS responses, revealed that the lymphocytic infiltrates vary in severity and composition among SS-patients, are full-blown at diagnosis and remain unchanged thereafter. Although the pathogenetic pathways underlying SS have not yet elucidated, it is well-established that glandular epithelial cells are central regulators of local autoimmune responses. Moreover, chronic inflammation affects epithelial function and phenotype, which strengthens or weakens their immunoregulatory/secretory function, leading to deterioration of autoimmune phenomena. Herein, the current findings regarding the autoimmune lesions, the role of epithelial cells and their interaction with infiltrating lymphocytic cells are discussed.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autoimmune responses; Infiltrates; Pathogenesis; Salivary gland epithelial cells; Sjögren's syndrome

Mesh:

Year:  2017        PMID: 28330683     DOI: 10.1016/j.clim.2017.03.007

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  24 in total

1.  MiR-let-7d-3p regulates IL-17 expression through targeting AKT1/mTOR signaling in CD4+ T cells.

Authors:  Jian Wang; Xin Wang; Longfei Wang; Chao Sun; Changhao Xie; Zhijun Li
Journal:  In Vitro Cell Dev Biol Anim       Date:  2019-11-25       Impact factor: 2.416

2.  Regional Differences following Partial Salivary Gland Resection.

Authors:  K J O'Keefe; K A DeSantis; A L Altrieth; D A Nelson; E Z M Taroc; A R Stabell; M T Pham; M Larsen
Journal:  J Dent Res       Date:  2019-11-25       Impact factor: 6.116

Review 3.  TIGIT as a Promising Therapeutic Target in Autoimmune Diseases.

Authors:  Chenran Yue; Sheng Gao; Shuting Li; Zhouhang Xing; Hengrong Qian; Ying Hu; Wenqian Wang; Chunyan Hua
Journal:  Front Immunol       Date:  2022-06-03       Impact factor: 8.786

Review 4.  Therapeutic Potential of Microvesicles in Cell Therapy and Regenerative Medicine of Ocular Diseases With an Especial Focus on Mesenchymal Stem Cells-Derived Microvesicles.

Authors:  Lina Moallemi Rad; Alexey V Yumashev; Bashdar Mahmud Hussen; Hazha Hadayat Jamad; Soudeh Ghafouri-Fard; Mohammad Taheri; Samaneh Rostami; Vahid Niazi; Mohammadreza Hajiesmaeili
Journal:  Front Genet       Date:  2022-03-29       Impact factor: 4.599

Review 5.  Rheumatic Manifestations in Patients Treated with Immune Checkpoint Inhibitors.

Authors:  Konstantinos Melissaropoulos; Kalliopi Klavdianou; Alexandra Filippopoulou; Fotini Kalofonou; Haralabos Kalofonos; Dimitrios Daoussis
Journal:  Int J Mol Sci       Date:  2020-05-11       Impact factor: 5.923

6.  Ly9 (CD229) Antibody Targeting Depletes Marginal Zone and Germinal Center B Cells in Lymphoid Tissues and Reduces Salivary Gland Inflammation in a Mouse Model of Sjögren's Syndrome.

Authors:  Joan Puñet-Ortiz; Manuel Sáez Moya; Marta Cuenca; Eduardo Caleiras; Adriana Lazaro; Pablo Engel
Journal:  Front Immunol       Date:  2018-11-16       Impact factor: 7.561

Review 7.  Subclinical Atherosclerosis in Primary Sjögren's Syndrome: Does Inflammation Matter?

Authors:  Elena Bartoloni; Alessia Alunno; Giacomo Cafaro; Valentina Valentini; Onelia Bistoni; Angelo Francesco Bonifacio; Roberto Gerli
Journal:  Front Immunol       Date:  2019-04-17       Impact factor: 7.561

Review 8.  Recent advances of exosomes in immune-mediated eye diseases.

Authors:  Na Li; Lu Zhao; Yankai Wei; Vicki L Ea; Hong Nian; Ruihua Wei
Journal:  Stem Cell Res Ther       Date:  2019-08-30       Impact factor: 6.832

9.  The Increased Ratio of Blood CD56bright NK to CD56dim NK Is a Distinguishing Feature of Primary Sjögren's Syndrome.

Authors:  Bingxia Ming; Tong Wu; Shaozhe Cai; Peng Hu; Jungen Tang; Fang Zheng; Cong Ye; Lingli Dong
Journal:  J Immunol Res       Date:  2020-07-09       Impact factor: 4.818

Review 10.  Involvement of Aquaporins in the Pathogenesis, Diagnosis and Treatment of Sjögren's Syndrome.

Authors:  Muhammad Shahnawaz Soyfoo; Clara Chivasso; Jason Perret; Christine Delporte
Journal:  Int J Mol Sci       Date:  2018-10-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.